BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26314686)

  • 1. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    te Riele AS; James CA; Groeneweg JA; Sawant AC; Kammers K; Murray B; Tichnell C; van der Heijden JF; Judge DP; Dooijes D; van Tintelen JP; Hauer RN; Calkins H; Tandri H
    Eur Heart J; 2016 Mar; 37(9):755-63. PubMed ID: 26314686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity.
    te Riele AS; James CA; Bhonsale A; Groeneweg JA; Camm CF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; Judge DP; Hauer RN; Tandri H; Calkins H
    Heart Rhythm; 2013 Oct; 10(10):1484-91. PubMed ID: 23816439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria.
    Cox MG; van der Smagt JJ; Noorman M; Wiesfeld AC; Volders PG; van Langen IM; Atsma DE; Dooijes D; Houweling AC; Loh P; Jordaens L; Arens Y; Cramer MJ; Doevendans PA; van Tintelen JP; Wilde AA; Hauer RN
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):126-33. PubMed ID: 20215590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.
    Groeneweg JA; van der Zwaag PA; Olde Nordkamp LR; Bikker H; Jongbloed JD; Jongbloed R; Wiesfeld AC; Cox MG; van der Heijden JF; Atsma DE; de Boer K; Doevendans PA; Vink A; van Veen TA; Dooijes D; van den Berg MP; Wilde AA; van Tintelen JP; Hauer RN
    Am J Cardiol; 2013 Oct; 112(8):1197-206. PubMed ID: 23871674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
    James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H
    J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations.
    Sawant AC; Bhonsale A; te Riele AS; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H; James CA
    J Am Heart Assoc; 2014 Dec; 3(6):e001471. PubMed ID: 25516436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
    te Riele AS; Bhonsale A; James CA; Rastegar N; Murray B; Burt JR; Tichnell C; Madhavan S; Judge DP; Bluemke DA; Zimmerman SL; Kamel IR; Calkins H; Tandri H
    J Am Coll Cardiol; 2013 Nov; 62(19):1761-9. PubMed ID: 23810894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
    Groeneweg JA; Bhonsale A; James CA; te Riele AS; Dooijes D; Tichnell C; Murray B; Wiesfeld AC; Sawant AC; Kassamali B; Atsma DE; Volders PG; de Groot NM; de Boer K; Zimmerman SL; Kamel IR; van der Heijden JF; Russell SD; Jan Cramer M; Tedford RJ; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Hauer RN; Calkins H
    Circ Cardiovasc Genet; 2015 Jun; 8(3):437-46. PubMed ID: 25820315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.
    Bhuiyan ZA; Jongbloed JD; van der Smagt J; Lombardi PM; Wiesfeld AC; Nelen M; Schouten M; Jongbloed R; Cox MG; van Wolferen M; Rodriguez LM; van Gelder IC; Bikker H; Suurmeijer AJ; van den Berg MP; Mannens MM; Hauer RN; Wilde AA; van Tintelen JP
    Circ Cardiovasc Genet; 2009 Oct; 2(5):418-27. PubMed ID: 20031616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome.
    Mast TP; Teske AJ; vd Heijden JF; Groeneweg JA; Te Riele AS; Velthuis BK; Hauer RN; Doevendans PA; Cramer MJ
    J Am Soc Echocardiogr; 2015 Sep; 28(9):1103-13.e9. PubMed ID: 26025724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Cox MG; van der Smagt JJ; Wilde AA; Wiesfeld AC; Atsma DE; Nelen MR; Rodriguez LM; Loh P; Cramer MJ; Doevendans PA; van Tintelen JP; de Bakker JM; Hauer RN
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):524-30. PubMed ID: 19843920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
    Bhonsale A; Groeneweg JA; James CA; Dooijes D; Tichnell C; Jongbloed JD; Murray B; te Riele AS; van den Berg MP; Bikker H; Atsma DE; de Groot NM; Houweling AC; van der Heijden JF; Russell SD; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Calkins H; Hauer RN
    Eur Heart J; 2015 Apr; 36(14):847-55. PubMed ID: 25616645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage.
    Mast TP; Teske AJ; Te Riele AS; Groeneweg JA; Van Der Heijden JF; Velthuis BK; Loh P; Doevendans PA; Van Veen TA; Dooijes D; De Bakker JM; Hauer RN; Cramer MJ
    J Cardiovasc Electrophysiol; 2016 Mar; 27(3):303-14. PubMed ID: 26585103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Mast TP; James CA; Calkins H; Teske AJ; Tichnell C; Murray B; Loh P; Russell SD; Velthuis BK; Judge DP; Dooijes D; Tedford RJ; van der Heijden JF; Tandri H; Hauer RN; Abraham TP; Doevendans PA; Te Riele AS; Cramer MJ
    JAMA Cardiol; 2017 Mar; 2(3):293-302. PubMed ID: 28097316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial form of arrhythmogenic right ventricular cardiomyopathy.
    Włodarska EK; Konka M; Kepski R; Zaleska T; Płoski R; Ruzyłło W; Janion M; Jaworska K; Rydlewska-Sadowska W; Hoffman P
    Kardiol Pol; 2004 Jan; 60(1):1-14. PubMed ID: 15004627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age.
    van der Pols MJ; Mast TP; Loh P; van der Heijden JF; Cramer MJ; Hauer RN; Te Riele AS
    Neth Heart J; 2016 Dec; 24(12):740-747. PubMed ID: 27580740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.